#VisualAbstract: Addition of everolimus to letrozole improves survival in patients with HR⁺ breast cancer and disease progression on tamoxifen
Click to read this study in JAMA Oncology.
Tag: hormone receptor (HR)
#VisualAbstract: Aromatase inhibitors superior to tamoxifen for progression-free survival in HR⁺ advanced breast cancer
Click to read the study in the European Journal of Cancer.
Quick Take: Overall survival with ribociclib plus endocrine therapy in breast cancer
Hormone therapy is the standard of care for premenopausal and postmenopausal women with hormone receptor-positive, human epidermal growth factor receptor2 ...
Quick Take: Genomic characterization of metastatic breast cancers
Several late-stage cancers have been shown to acquire genomic alterations during disease evolution. In patients with breast cancer, 20% of ...